Spine authors respond to letter on tirzepatide and lumbar fusion complications

The wire

1. 01Spine published the authors' response to a letter to the editor concerning their study of long-term mechanical complications after lumbar fusion in patients receiving tirzepatide compared with other GLP-1 receptor agonists.
2. 02Surgeons and prescribers weighing incretin therapy around spinal fusion are tracking this exchange for caveats on the original comparison.
3. 03The item is correspondence rather than new data; the underlying study's findings and limitations remain the substance of the debate.

From the source

Response to Letter to the Editor regarding "Long-Term Mechanical Complications After Lumbar Fusion in Patients Receiving Tirzepatide vs Other GLP-1 Receptor Agonists"

Spine · 2026 Sep 16 · Wang R, Islam H, Karikaran A et al.